Safety and pharmacokinetics of anti‐TFPI antibody (concizumab) in healthy volunteers and patients with hemophilia: a randomized first human dose trial
Authors
Pratima Chowdary•Stefan Lethagen•Pantep Angchaisuksiri
Journal
Journal of Thrombosis and Haemostasis
Published
January 31, 2015
Sign in to comment
Add a comment...
Supporters
Support the authors with ResearchCoin
Topics
DOI
License
Unknown License
No comments yet. Start the conversation!
Your contribution could help open science.